Baird Financial Group
RMD icon

Baird Financial Group’s ResMed RMD Stock Holding History

Baird Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.8M Sell
105,940
-24,374
-19% -$6.07M 0.04% 325
2025
Q4 		$31.4M Sell
130,314
-28,133
-18% -$7.19M 0.05% 258
2025
Q3 		$43.4M Sell
158,447
-40,912
-21% -$11.2M 0.07% 201
2025
Q2 		$51.4M Sell
199,359
-15,435
-7% -$3.68M 0.09% 185
2025
Q1 		$48.1M Buy
214,794
+49,723
+30% +$11.6M 0.09% 185
2024
Q4 		$37.8M Sell
165,071
-15,820
-9% -$3.81M 0.07% 238
2024
Q3 		$44.2M Sell
180,891
-23,871
-12% -$5.33M 0.09% 220
2024
Q2 		$39.2M Sell
204,762
-222,677
-52% -$45.2M 0.08% 231
2024
Q1 		$84.6M Buy
427,439
+4,498
+1% +$824K 0.18% 131
2023
Q4 		$72.8M Sell
422,941
-11,097
-3% -$1.7M 0.17% 150
2023
Q3 		$64.2M Buy
434,038
+108,887
+33% +$19.7M 0.18% 135
2023
Q2 		$71M Buy
325,151
+83,773
+35% +$18.7M 0.19% 130
2023
Q1 		$52.9M Sell
241,378
-103,969
-30% -$22.6M 0.13% 173
2022
Q4 		$71.9M Buy
345,347
+43,223
+14% +$9.5M 0.19% 121
2022
Q3 		$66M Sell
302,124
-73,495
-20% -$16.7M 0.19% 125
2022
Q2 		$78.7M Buy
375,619
+683
+0.2% +$145K 0.22% 106
2022
Q1 		$90.9M Buy
374,936
+7,642
+2% +$1.85M 0.22% 98
2021
Q4 		$95.7M Buy
367,294
+36,006
+11% +$9.34M 0.22% 103
2021
Q3 		$87.3M Buy
331,288
+921
+0.3% +$252K 0.22% 108
2021
Q2 		$81.4M Sell
330,367
-3,550
-1% -$746K 0.21% 122
2021
Q1 		$64.8M Sell
333,917
-23,599
-7% -$4.73M 0.18% 140
2020
Q4 		$76M Sell
357,516
-5,547
-2% -$1.11M 0.23% 116
2020
Q3 		$62.2M Sell
363,063
-14,902
-4% -$2.75M 0.21% 125
2020
Q2 		$72.6M Buy
377,965
+372,665
+7,031% +$61M 0.27% 88
2020
Q1 		$781K Sell
5,300
-507
-9% -$80.8K ﹤0.01% 941
2019
Q4 		$900K Sell
5,807
-70
-1% -$10.1K ﹤0.01% 989
2019
Q3 		$794K Buy
5,877
+476
+9% +$62.4K ﹤0.01% 1035
2019
Q2 		$659K Buy
5,401
+1
+0% +$111 ﹤0.01% 1120
2019
Q1 		$561K Sell
5,400
-304
-5% -$31.4K ﹤0.01% 1000
2018
Q4 		$650K Buy
5,704
+1
+0% +$107 ﹤0.01% 908
2018
Q3 		$657K Sell
5,703
-123
-2% -$13.5K ﹤0.01% 966
2018
Q2 		$603K Buy
5,826
+24
+0.4% +$2.43K ﹤0.01% 956
2018
Q1 		$571K Hold
5,802
– – ﹤0.01% 981
2017
Q4 		$491K Hold
5,802
– – ﹤0.01% 1017
2017
Q3 		$447K Buy
5,802
+2
+0% +$153 ﹤0.01% 1015
2017
Q2 		$452K Hold
5,800
– – ﹤0.01% 988
2017
Q1 		$417K Sell
5,800
-123
-2% -$8.5K ﹤0.01% 996
2016
Q4 		$368K Sell
5,923
-1,362
-19% -$83.4K ﹤0.01% 1000
2016
Q3 		$472K Sell
7,285
-6,102
-46% -$406K ﹤0.01% 954
2016
Q2 		$861K Sell
13,387
-77
-0.6% -$4.54K 0.01% 779
2016
Q1 		$778K Buy
13,464
+5,076
+61% +$287K 0.01% 791
2015
Q4 		$450K Buy
8,388
+1,782
+27% +$100K ﹤0.01% 936
2015
Q3 		$337K Buy
6,606
+56
+0.9% +$3.01K ﹤0.01% 1025
2015
Q2 		$369K Buy
+6,550
New +$413K ﹤0.01% 1066

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baird Financial Group's RMD Position: Q1 2026 in Review

Baird Financial Group reduced its ResMed (RMD) stake by 19% in Q1 2026, selling an estimated $6.07M and leaving 105,940 shares worth $23.8M. The position accounts for 0.04% of the portfolio, ranked #325.

Baird Financial Group first reported a position in RMD in Q2 2015 and has held it in 44 quarters since. The position peaked at $95.7M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Baird Financial Group held 105,940 shares of ResMed worth $23.8M as of Q1 2026.
  • Baird Financial Group sold 24,374 ResMed shares in Q1 2026, an estimated $6.07M.
  • ResMed made up 0.04% of Baird Financial Group's portfolio in Q1 2026, its #325 holding.
  • Baird Financial Group first reported a position in ResMed in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's ResMed position peaked at $95.7M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.